...
首页> 外文期刊>National Journal of Medical Research >Correlation of Vitamin B12 Deficiency with Metformin Therapy in Indian Type 2 Diabetes Mellitus Patients
【24h】

Correlation of Vitamin B12 Deficiency with Metformin Therapy in Indian Type 2 Diabetes Mellitus Patients

机译:印度2型糖尿病患者的二甲双胍疗法维生素B12缺乏的相关性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

"Introduction: Diabetes is non-communicable disease prevalent all over the world. Metformin is most commonly prescribed and first line anti-hyperglycaemic medication of type 2 diabetes mellitus patients. Vitamin B12- Intrinsic factor complex uptake by ileal cell surface receptors is a known to be a process dependent on calcium availability. Metformin affects calcium dependant membrane action. Hence intestinal absorption of Vitamin B12 is often decreased during chronic metformin therapy. Aims & Objectives: This study is done to assess the prevalence, severity and clinical implication of vitamin B12 deficiency in type 2 diabetes mellitus patients taking chronic metformin therapy. Methods: The study included total 50 type 2 diabetes patients as per inclusion and exclusion criteria. Detailed history, physical examination and laboratory evaluation CBC, peripheral blood smear, renal function test, FBS,PPBS, HbA1c, serum vitamin B12 assay, urine routine & microscopy of all 50 patients. Analysis was done with help of SPSS software and using Microsoft Excel 2012. Results: In our study, dosage of the metformin was highest among deficient group followed by borderline and normal. The mean duration of therapy with metformin is high in the deficient group. Hence the duration of therapy with metformin and the dose determines the development of vitamin deficiency. With duration of metformin and duration of diabetes showed non-significant P value which may be due to the small sample size. As it is a cross sectional study, the population is very low and it is difficult to study the P value in this population. But the mean value shows good correlation with duration and dosage of metformin therapy and duration of diabetes with B12 deficiency. Conclusion: Chronic metformin therapy is associated with B12 deficiency by causing asymptomatic vitamin B12 deficiency. Vitamin B12 level in the patients who were on chronic metformin therapy is useful to predict B12 deficiency as they are prone for B12 deficiency. The duration and dose of metformin therapy has affected the vitamin B12 status of type 2 diabetes mellitus patients. ".
机译:“介绍:糖尿病是世界各地的非传染性疾病。二甲双胍是2型糖尿病患者的最常见规定的和第一线抗高血糖药物。维生素B12-内在因子复杂的eLEAL细胞表面受体的复合吸收是一种已知的依赖于钙可用性的过程。二甲双胍影响钙依赖性膜作用。因此,维生素B12的肠道吸收通常在慢性二甲双胍治疗期间降低。目标与目标:本研究进行了评估维生素B12缺乏的患病率,严重程度和临床意义。在2型糖尿病患者服用慢性二甲双胍治疗。方法:该研究包括夹杂制和排除标准的总5种2型糖尿病患者。详细历史,体检和实验室评估CBC,外周血涂片,肾功能测试,FBS,PPBS ,HBA1C,血清维生素B12测定,所有50名患者的尿常规和显微镜。分析是在SPSS软件的帮助下完成的,并使用Microsoft Excel 2012.结果:在我们的研究中,二甲双胍的剂量在缺陷组中最高,其次是边界和正常的。缺陷组中,二甲双胍的平均治疗持续时间高。因此,用二甲双胍和剂量治疗持续时间决定了维生素缺乏的发展。患有二甲双胍的持续时间和糖尿病持续时间显示出的非显着P值,其可能是由于小的样本尺寸。由于它是一个横截面研究,人口非常低,很难研究该群体的P值。但平均值显示出与二甲双胍治疗的持续时间和剂量良好的相关性和B12缺乏的糖尿病持续时间。结论:慢性二甲双胍治疗通过引起无症状维生素B12缺乏与B12缺乏有关。在慢性二甲双胍治疗的患者中维生素B12水平可用于预测B12缺乏,因为它们易于对B12缺乏症。二甲双胍治疗的持续时间和剂量影响了2型糖尿病患者的维生素B12状态。 “。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号